Early Cancer Institute, University of Cambridge, Cambridge, UK.
Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Nat Commun. 2023 Jul 15;14(1):4239. doi: 10.1038/s41467-023-39957-6.
A variety of mutational processes drive cancer development, but their dynamics across the entire disease spectrum from pre-cancerous to advanced neoplasia are poorly understood. We explore the mutagenic processes shaping oesophageal adenocarcinoma tumorigenesis in 997 instances comprising distinct stages of this malignancy, from Barrett Oesophagus to primary tumours and advanced metastatic disease. The mutational landscape is dominated by the C[T > C/G]T substitution enriched signatures SBS17a/b, which are linked with TP53 mutations, increased proliferation, genomic instability and disease progression. The APOBEC mutagenesis signature is a weak but persistent signal amplified in primary tumours. We also identify prevalent alterations in DNA damage repair pathways, with homologous recombination, base and nucleotide excision repair and translesion synthesis mutated in up to 50% of the cohort, and surprisingly uncoupled from transcriptional activity. Among these, the presence of base excision repair deficiencies show remarkably poor prognosis in the cohort. In this work, we provide insights on the mutational aetiology and changes enabling the transition from pre-neoplastic to advanced oesophageal adenocarcinoma.
多种突变过程驱动癌症的发展,但它们在从癌前病变到进展期肿瘤的整个疾病谱中的动态变化仍知之甚少。我们研究了 997 例不同阶段的食管腺癌肿瘤发生过程中的突变过程,这些病例涵盖了这种恶性肿瘤的不同阶段,从巴雷特食管到原发性肿瘤和晚期转移性疾病。突变景观主要由 C[T>C/G]T 取代富集的 SBS17a/b 签名主导,这些签名与 TP53 突变、增殖增加、基因组不稳定性和疾病进展有关。APOBEC 诱变特征是一个较弱但持续存在的信号,在原发性肿瘤中被放大。我们还发现 DNA 损伤修复途径中普遍存在改变,同源重组、碱基和核苷酸切除修复以及跨损伤合成在多达 50%的队列中发生突变,令人惊讶的是,这些改变与转录活性无关。在这些改变中,碱基切除修复缺陷的存在在该队列中显示出明显较差的预后。在这项工作中,我们提供了关于突变病因学和使从癌前病变向进展期食管腺癌转变的改变的见解。